Cross-Regional Pitch & Match session

12 Jun 2025 | Park Inn by Radisson Leuven -

SAGITTA BIOTECH

Drug discovery companies

www.sagittabiotech.comLiège, Belgium
1 profile visit

About

Sagitta Biotech is developing innovative therapies against infectious diseases and cancer based on its viral vector/mRNA platform.

The technology allows us to develop very quickly vaccines that are safe and effective, but also to manufacture them at a very low cost (cents per dose) thanks to a "constant manufacturing process" (identical for all vaccines).

This allows us to get significant shortcuts during development, and reduce the cost of operations for our customers.

MANUFACTURING AND PRODUCTION

Bioprocessing and biomanufacturingVaccine manufacturing

THERAPEUTIC AREAS

ImmunologyInfectious diseasesOncology

CLINICAL DEVELOPMENT AND TRIALS

Infectious diseasesOncology

RESEARCH AND DEVELOPMENT

Vaccine developmentVaccine delivery systemsVaccine platformsViral vectors

Representatives

Benjamin DAMIEN

CEO

SAGITTA BIOTECH